|
1
|
Pan BT and Johnstone RM: Fate of the
transferrin receptor during maturation of sheep reticulocytes in
vitro: Selective externalization of the receptor. Cell. 33:967–978.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Boil Chem. 262:9412–9420. 1987.
|
|
3
|
Yu S, Cao H, Shen B and Feng J:
Tumor-derived exosomes in cancer progression and treatment failure.
Oncotarget. 6:37151–37168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Isola AL and Chen S: Exosomes: The link
between GPCR activation and metastatic potential? Front Genet.
7:562016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ciardiello C, Cavallini L, Spinelli C,
Yang J, Reis-Sobreiro M, de Candia P, Minciacchi VR and Di Vizio D:
Focus on extracellular vesicles: New frontiers of cell-to-cell
communication in cancer. Int J Mol Sci. 17:1752016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taverna S, Giallombardo M, Gil-Bazo I,
Carreca AP, Castiglia M, Chacartegui J, Araujo A, Alessandro R,
Pauwels P, Peeters M and Rolfo C: Exosomes isolation and
characterization in serum is feasible in non-small cell lung cancer
patients: Critical analysis of evidence and potential role in
clinical practice. Oncotarget. 7:28748–28760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fu H, Yang H, Zhang X and Xu W: The
emerging roles of exosomes in tumor-stroma interaction. J Cancer
Res Clin Oncol. 142:1897–1907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soung YH, Nguyen T, Cao H, Lee J and Chung
J: Emerging roles of exosomes in cancer invasion and metastasis.
BMB Rep. 49:18–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rahman MA, Barger JF, Lovat F, Gao M,
Otterson GA and Nana-Sinkam P: Lung cancer exosomes as drivers of
epithelial mesenchymal transition. Oncotarget. 7:54852–54866. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Yi J, Chen X, Zhang Y, Xu M and
Yang Z: The regulation of cancer cell migration by lung cancer
cell-derived exosomes through TGF-β and IL-10. Oncol Lett.
11:1527–1530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bobrie A and Thery C: Unraveling the
physiological functions of exosome secretion by tumors.
Oncoimmunology. 2:e225652013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Toro J, Herschlik L, Waldner C and
Mongini C: Emerging roles of exosomes in normal and pathological
conditions: New insights for diagnosis and therapeutic
applications. Front Immunol. 6:2032015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim KM, Abdelmohsen K, Mustapic M,
Kapogiannis D and Gorospe M: RNA in extracellular vesicles. Wiley
Interdiscip Rev RNA. 8:2017. View Article : Google Scholar
|
|
14
|
Neviani P and Fabbri M: Exosomic microRNAs
in the tumor microenvironment. Front Med (Lausanne).
2:472015.PubMed/NCBI
|
|
15
|
Martin F, Roth DM, Jans DA, Pouton CW,
Partridge LJ, Monk PN and Moseley GW: Tetraspanins in viral
infections: A fundamental role in viral biology? J Virol.
79:10839–10851. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baietti MF, Zhang Z, Mortier E, Melchior
A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C,
Vermeiren E, et al: Syndecan-syntenin-ALIX regulates the biogenesis
of exosomes. Nat Cell Biol. 14:677–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fares J, Kashyap R and Zimmermann P:
Syntenin: Key player in cancer exosome biogenesis and uptake? Cell
Adh Migr. 11:124–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ghossoub R, Lembo F, Rubio A, Gaillard CB,
Bouchet J, Vitale N, Slavík J, Machala M and Zimmermann P:
Syntenin-ALIX exosome biogenesis and budding into multivesicular
bodies are controlled by ARF6 and PLD2. Nat Commun. 5:34772014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shim S: Role and regulation of ESCRT-III
In multivesiculr body biogenesis. All Theses and Dissertations
(ETDs). 3232009.
|
|
20
|
Roxrud I, Stenmark H and Malerod L: ESCRT
& Co. Biol Cell. 102:293–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Votteler J and Sundquist WI: Virus budding
and the ESCRT pathway. Cell Host Microbe. 14:232–241. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amano M, Nakayama M and Kaibuchi K:
Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell
polarity. Cytoskeleton (Hoboken). 67:545–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roucourt B, Meeussen S, Bao J, Zimmermann
P and David G: Heparanase activates the syndecan-syntenin-ALIX
exosome pathway. Cell Res. 25:412–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roma-Rodrigues C, Fernandes AR and
Baptista PV: Exosome in tumour microenvironment: Overview of the
crosstalk between normal and cancer cells. Biomed Res Int.
2014:1794862014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gezer U, Ozgur E, Cetinkaya M, Isin M and
Dalay N: Long non-coding RNAs with low expression levels in cells
are enriched in secreted exosomes. Cell Biol Int. 38:1076–1079.
2014.PubMed/NCBI
|
|
26
|
Schageman J, Zeringer E, Li M, Barta T,
Lea K, Gu J, Magdaleno S, Setterquist R and Vlassov AV: The
complete exosome workflow solution: From isolation to
characterization of RNA cargo. Biomed Res Int. 2013:2539572013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Batagov AO, Kuznetsov VA and Kurochkin IV:
Identification of nucleotide patterns enriched in secreted RNAs as
putative cis-acting elements targeting them to exosome
nano-vesicles. BMC Genomics. 3 (Suppl 12):S182011. View Article : Google Scholar
|
|
28
|
Okazaki Y, Furuno M, Kasukawa T, Adachi J,
Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, et al:
Analysis of the mouse transcriptome based on functional annotation
of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kapranov P, Cheng J, Dike S, Nix DA,
Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J,
Hofacker IL, et al: RNA maps reveal new RNA classes and a possible
function for pervasive transcription. Science. 316:1484–1488. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Perkel JM: Visiting ‘noncodarnia’.
Biotechniques. 54:301 303–304. 2013. View Article : Google Scholar
|
|
31
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sato-Kuwabara Y, Melo SA, Soares FA and
Calin GA: The fusion of two worlds: Non-coding RNAs and
extracellular vesicles-diagnostic and therapeutic implications
(Review). Int J Oncol. 46:17–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bolha L, Ravnik-Glavac M and Glavac D:
Long noncoding RNAs as biomarkers in cancer. Dis Markers.
2017:72439682017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hewson C and Morris KV: Form and function
of exosome-associated long non-coding RNAs in cancer. Curr Top
Microbiol Immunol. 394:41–56. 2016.PubMed/NCBI
|
|
35
|
Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau
DJ, Sarma K, Song JJ, Kingston RE, Borowsky M and Lee JT:
Genome-wide identification of polycomb-associated RNAs by RIP-seq.
Mol Cell. 40:939–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shih JW and Kung HJ: Long non-coding RNA
and tumor hypoxia: New players ushered toward an old arena. J
Biomed Sci. 24:532017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Berrondo C, Flax J, Kucherov V, Siebert A,
Osinski T, Rosenberg A, Fucile C, Richheimer S and Beckham CJ:
Expression of the long non-coding RNA HOTAIR correlates with
disease progression in bladder cancer and is contained in bladder
cancer patient urinary exosomes. PLoS One. 11:e01472362016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan TH, Lu SW, Huang YQ, Que GB, Chen JH,
Chen YP, et al: Upregulation of the long noncoding RNA HOTAIR
predicts recurrence in stage Ta/T1 bladder cancer. Tumour biology:
the journal of the International Society for Oncodevelopmental
Biology and Medicine. 2014.35(10): 10249–57. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xie Z, Chen X, Li J, Guo Y, Li H, Pan X,
Jiang J, Liu H and Wu B: Salivary HOTAIR and PVT1 as novel
biomarkers for early pancreatic cancer. Oncotarget. 7:25408–25419.
2016.PubMed/NCBI
|
|
40
|
Wang J, Zhang X, Ji C, Zhang L, Di Y, Lou
W, Zhang X and X J: Novel implications of exosomes and lncRNAs in
the diagnosis and treatment of pancreatic cancer. Novel
Implications of Exosomes in Diagnosis and Treatment of Cancer and
Infectious Diseases. Wang J; IntechOpen, : 2017, https://www.intechopen.com/books/novel-implications-of-exosomes-in-diagnosis-and-treatment-of-cancer-and-infectious-diseases/novel-implications-of-exosomes-and-lncrnas-in-the-diagnosis-and-treatment-of-pancreatic-cancer09th–May.
2019 View Article : Google Scholar
|
|
41
|
Song J, Kim D, Han J, Kim Y, Lee M and Jin
EJ: PBMC and exosome-derived Hotair is a critical regulator and
potent marker for rheumatoid arthritis. Clin Exp Med. 15:121–126.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1
protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gutschner T, Hammerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang JK, Ma L, Song WH, Lu BY, Huang YB,
Dong HM, Ma XK, Zhu ZZ and Zhou R: LncRNA-MALAT1 promotes
angiogenesis of thyroid cancer by modulating tumor-associated
macrophage FGF2 protein secretion. J Cell Biochem. 118:4821–4830.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Askarian-Amiri ME, Crawford J, French JD,
Smart CE, Smith MA, Clark MB, Ru K, Mercer TR, Thompson ER, Lakhani
SR, et al: SNORD-host RNA Zfas1 is a regulator of mammary
development and a potential marker for breast cancer. RNA.
17:878–891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pan L, Liang W, Fu M, Huang ZH, Li X,
Zhang W, Zhang P, Qian H, Jiang PC, Xu WR and Zhang X:
Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes
gastric cancer progression. J Cancer Res Clin Oncol. 143:991–1004.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou H, Wang F, Chen H, Tan Q, Qiu S, Chen
S, Jing W, Yu M, Liang C, Ye S and Tu J: Increased expression of
long-noncoding RNA ZFAS1 is associated with epithelial-mesenchymal
transition of gastric cancer. Aging (Albany NY). 8:2023–2038. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Matouk IJ, Halle D, Raveh E, Gilon M,
Sorin V and Hochberg A: The role of the oncofetal H19 lncRNA in
tumor metastasis: Orchestrating the EMT-MET decision. Oncotarget.
7:3748–3765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Conigliaro A, Costa V, Lo Dico A, Saieva
L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M,
et al: CD90+ liver cancer cells modulate endothelial cell phenotype
through the release of exosomes containing H19 lncRNA. Mol Cancer.
14:1552015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
George J and Patel T: Noncoding RNA as
therapeutic targets for hepatocellular carcinoma. Semin Liver Dis.
35:63–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lang HL, Hu GW, Chen Y, Liu Y, Tu W, Lu
YM, Wu L and Xu GH: Glioma cells promote angiogenesis through the
release of exosomes containing long non-coding RNA POU3F3. Eur Rev
Med Pharmacol Sci. 21:959–972. 2017.PubMed/NCBI
|
|
53
|
Hu C, Chen M, Jiang R, Guo Y, Wu M and
Zhang X: Exosome-related tumor microenvironment. Journal of Cancer.
2018.9(17): 3084–92. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mitra SA, Mitra AP and Triche TJ: A
central role for long non-coding RNA in cancer. Front Genet.
3:172012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Braconi C, Valeri N, Kogure T, Gasparini
P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T:
Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl
Acad Sci USA. 108:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kogure T, Yan IK, Lin WL and Patel T:
Extracellular vesicle-mediated transfer of a novel long noncoding
RNA TUC339: A mechanism of intercellular signaling in human
hepatocellular cancer. Genes Cancer. 4:261–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Takahashi K, Yan IK, Kogure T, Haga H and
Patel T: Extracellular vesicle-mediated transfer of long non-coding
RNA ROR modulates chemosensitivity in human hepatocellular cancer.
FEBS Open Bio. 4:458–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li Y, Jiang B, Zhu H, Qu X, Zhao L, Tan Y,
Jiang Y, Liao M and Wu X: Inhibition of long non-coding RNA ROR
reverses resistance to Tamoxifen by inducing autophagy in breast
cancer. Tumour Biol. 39:10104283177057902017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yang N, Li S, Li G, Zhang S, Tang X, Ni S,
Jian X, Xu C, Zhu J and Lu M: The role of extracellular vesicles in
mediating progression, metastasis and potential treatment of
hepatocellular carcinoma. Oncotarget. 8:3683–3695. 2017.PubMed/NCBI
|
|
60
|
Takahashi K, Yan IK, Wood J, Haga H and
Patel T: Involvement of extracellular vesicle long noncoding RNA
(linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer
Res. 12:1377–1387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fritah S, Niclou SP and Azuaje F:
Databases for lncRNAs: A comparative evaluation of emerging tools.
RNA. 20:1655–1665. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mourtada-Maarabouni M, Pickard MR, Hedge
VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA,
controls apoptosis and is downregulated in breast cancer. Oncogene.
28:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lucafò M, Stocco G and Decorti GJTCR:
Emerging molecular mechanisms underlying cancer metastasis: The
rising role of the long non-coding RNA GAS5. Transl Cancer Res. 5
(Suppl 4):S827–S830. 2016. View Article : Google Scholar
|
|
64
|
Pickard MR, Mourtada-Maarabouni M and
Williams GT: Long non-coding RNA GAS5 regulates apoptosis in
prostate cancer cell lines. Biochim Biophys Acta. 1832:1613–1623.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kino T, Hurt DE, Ichijo T, Nader N and
Chrousos GP: Noncoding RNA gas5 is a growth arrest- and
starvation-associated repressor of the glucocorticoid receptor. Sci
Signal. 3:ra82010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
O'Leary VB, Hain S, Maugg D, Smida J,
Azimzadeh O, Tapio S, Ovsepian SV and Atkinson MJ: Long non-coding
RNA PARTICLE bridges histone and DNA methylation. Sci Rep.
7:17902017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
O'Leary VB, Ovsepian SV, Carrascosa LG,
Buske FA, Radulovic V, Niyazi M, Moertl S, Trau M, Atkinson MJ and
Anastasov N: PARTICLE, a triplex-forming long ncrna, regulates
locus-specific methylation in response to low-dose irradiation.
Cell Rep. 11:474–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Deng J, Tang J, Wang G and Zhu YS: Long
non-coding RNA as potential biomarker for prostate cancer: Is it
making a difference? Int J Environ Res Public Health. 14:E2702017.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang X, Arai S, Song X, Reichart D, Du K,
Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R: Induced
ncRNAs allosterically modify RNA-binding proteins in cis to inhibit
transcription. Nature. 454:126–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Di Liegro CM, Schiera G and Di Liegro I:
Extracellular vesicle-associated RNA as a carrier of epigenetic
information. Genes (Basel). 8:E2402017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hewson C, Capraro D, Burdach J, Whitaker N
and Morris KV: Extracellular vesicle associated long non-coding
RNAs functionally enhance cell viability. Noncoding RNA Res.
1:3–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Shi T, Gao G and Cao Y: Long noncoding
RNAs as novel biomarkers have a promising future in cancer
diagnostics. Dis Markers. 2016:90851952016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Akers JC, Gonda D, Kim R, Carter BS and
Chen CC: Biogenesis of extracellular vesicles (EV): Exosomes,
microvesicles, retrovirus-like vesicles, and apoptotic bodies. J
Neurooncol. 113:1–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Silva A, Bullock M and Calin G: The
clinical relevance of long non-coding RNAs in cancer. Cancers
(Basel). 7:2169–2182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Khurana R, Ranches G, Schafferer S,
Lukasser M, Rudnicki M, Mayer G and Hüttenhofer A: Identification
of urinary exosomal noncoding RNAs as novel biomarkers in chronic
kidney disease. RNA. 23:142–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Takahashi K, Yan IK, Haga H and Patel T:
Modulation of hypoxia-signaling pathways by extracellular linc-RoR.
J Cell Sci. 127:1585–1594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Gutschner T, Richtig G, Haemmerle M and
Pichler M: From biomarkers to therapeutic targets-the promises and
perils of long non-coding RNAs in cancer. Cancer Metastasis Rev.
37:83–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Rao AKDM, Rajkumar T and Mani S:
Perspectives of long non-coding RNAs in cancer. Mol Boil Rep.
44:203–18. 2017. View Article : Google Scholar
|
|
81
|
Smaldone MC and Davies BJ: BC-819, a
plasmid comprising the H19 gene regulatory sequences and diphtheria
toxin A, for the potential targeted therapy of cancers. Curr Opin
Mol Ther. 12:607–616. 2010.PubMed/NCBI
|
|
82
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wu R, Su Y, Wu H, Dai Y, Zhao M and Lu Q:
Characters, functions and clinical perspectives of long non-coding
RNAs. Mol Genet Genomics. 291:1013–1033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Qi P, Zhou XY and Du X: Circulating long
non-coding RNAs in cancer: Current status and future perspectives.
Mol Cancer. 15:392016. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Schmidt O and Teis D: The ESCRT machinery.
Curr Biol. 22:R116–R120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Keller S, Sanderson MP, Stoeck A and
Altevogt P: Exosomes: From biogenesis and secretion to biological
function. Immunol Lett. 107:102–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Ruiz-Martinez M, Navarro A, Marrades RM,
Vinolas N, Santasusagna S, Munoz C, Ramírez J, Molins L and Monzo
M: YKT6 expression, exosome release, and survival in non-small cell
lung cancer. Oncotarget. 7:51515–51524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yang C and Robbins PD: The roles of
tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol.
2011:8428492011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang A, Zhou N, Huang J, Liu Q, Fukuda K,
Ma D, Lu Z, Bai C, Watabe K and Mo YY: The human long non-coding
RNA-RoR is a p53 repressor in response to DNA damage. Cell Res.
23:340–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhang J, Liu SC, Luo XH, Tao GX, Guan M,
Yuan H and Hu DK: Exosomal long noncoding RNAs are differentially
expressed in the cervicovaginal lavage samples of cervical cancer
patients. J Clin Lab Anal. 30:1116–1121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Boil Ther. 17:104–113. 2016. View Article : Google Scholar
|
|
94
|
Shao Y, Ye M, Li Q, Sun W, Ye G, Zhang X,
Yang Y, Xiao B and Guo J: LncRNA-RMRP promotes carcinogenesis by
acting as a miR-206 sponge and is used as a novel biomarker for
gastric cancer. Oncotarget. 7:37812–37824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Xue M, Chen W, Xiang A, Wang R, Chen H,
Pan J, Pang H, An H, Wang X, Hou H and Li X: Hypoxic exosomes
facilitate bladder tumor growth and development through
transferring long non-coding RNA-UCA1. Mol Cancer. 16:1432017.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Juni RP, Abreu RC and da Costa Martins PA:
Regulation of microvascularization in heart failure-an endothelial
cell, non-coding RNAs and exosome liaison. Noncoding RNA Res.
2:45–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lu Z, Xiao Z, Liu F, Cui M, Li W, Yang Z,
Li J, Ye L and Zhang X: Long non-coding RNA HULC promotes tumor
angiogenesis in liver cancer by up-regulating sphingosine kinase 1
(SPHK1). Oncotarget. 7:241–254. 2016.PubMed/NCBI
|
|
99
|
Tan J, Qiu K, Li M and Liang Y:
Double-negative feedback loop between long non-coding RNA TUG1 and
miR-145 promotes epithelial to mesenchymal transition and
radioresistance in human bladder cancer cells. FEBS Lett.
589:3175–3181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Qin CF and Zhao FL: Long non-coding RNA
TUG1 can promote proliferation and migration of pancreatic cancer
via EMT pathway. Eur Rev Med Pharmacol Sci. 21:2377–2384.
2017.PubMed/NCBI
|
|
101
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
102
|
Lang HL, Hu GW, Zhang B, Kuang W, Chen Y,
Wu L and Xu GH: Glioma cells enhance angiogenesis and inhibit
endothelial cell apoptosis through the release of exosomes that
contain long non-coding RNA CCAT2. Oncol Rep. 38:785–798. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Liu T, Zhang X, Gao S, Jing F, Yang Y, Du
L, Zheng G, Li P, Li C and Wang C: Exosomal long noncoding RNA
CRNDE-h as a novel serum-based biomarker for diagnosis and
prognosis of colorectal cancer. Oncotarget. 7:85551–85563. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Isin M, Uysaler E, Ozgur E, Koseoglu H,
Sanli O, Yucel OB, Gezer U and Dalay N: Exosomal lncRNA-p21 levels
may help to distinguish prostate cancer from benign disease. Front
Genet. 6:1682015.PubMed/NCBI
|
|
105
|
Wang Y, Liu XJ and Yao XD: Function of
PCA3 in prostate tissue and clinical research progress on
developing a PCA3 score. Chin J Cancer Res. 26:493–500.
2014.PubMed/NCBI
|
|
106
|
Godinho M, Meijer D, Setyono-Han B,
Dorssers LC and van Agthoven T: Characterization of BCAR4, a novel
oncogene causing endocrine resistance in human breast cancer cells.
J Cell Physiol. 226:1741–1749. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Jang SY, Kim G, Park SY, Lee YR, Kwon SH,
Kim HS, Yoon JS, Lee JS, Kweon YO, Ha HT, et al: Clinical
significance of lncRNA-ATB expression in human hepatocellular
carcinoma. Oncotarget. 8:78588–78597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Pang Q, Ge J, Shao Y, Sun W, Song H, Xia
T, Xiao B and Guo J: Increased expression of long intergenic
non-coding RNA LINC00152 in gastric cancer and its clinical
significance. Tumour Biol. 35:5441–5447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Xu N, Chen F, Wang F, Lu X, Wang X, Lv M
and Lu C: Clinical significance of high expression of circulating
serum lncRNA RP11-445H22.4 in breast cancer patients: A Chinese
population-based study. Tumour Biol. 36:7659–7665. 2015. View Article : Google Scholar : PubMed/NCBI
|
